Our vision
Disrupting neuroscience
Give patients hope
Give patients hope
We are convinced that NETRI’s expertise can bring hope to patients with neurological diseases by inventing innovative and high-end technologies and services, that are not yet available on the market. New and disruptive approaches can be invented, through:
UNDERSTANDING
MODELLING
IMPROVING EXISTING TREATMENTS
REDUCTION OF ANIMAL TESTING
Our mission
NETRI can change the way neurological diseases are treated, by acting and thinking differently
We are committed to:
- Increasing discoveries on the brain and neurology
- Contributing to the invention of new, personalized, and relevant disruptive treatment approaches
- Speeding up the market entry of these approaches
- Alleviating the suffering of patients and their relatives
- Ethic position on animal testing
Our strategic priorities
We believe neurological disorders need an urgent response and are therefore our top strategic investment priorities

Our R&D programs
We are committed to continuously investing in research programs to:
- Develop new in vitro models and demonstrate their physiological relevance: neurofluidic models of Alzheimer’s and Parkison’s diseases and their injuries, degeneration of Lewy body, Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Lobar Degeneration (FLD), gut-brain axis and innervated epidermis
- Develop Standard Operating Protocols (SOP) for human induced pluripotent stem cells (iPScs) and patient-derived iPSCs differentiated neurons in our neurofluidic devices
- Develop the first in vitro differential diagnostic medical device for neurological troubles, in collaboration with Lyon’s Hospital
- Seeking partners for joint development with pharmaceutical industrials
OUR FACILITIES
NETRI controls its entire production chain
R&D Biolabs
Production laboratory
OUR PARTNERS
ACADEMIC PARTNERS
INDUSTRY ASSOCIATIONS
BUSINESS PARTNERS
INSTITUTIONAL PARTNERS
OUR CLIENTS
OUR DISTINCTIONS